AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 770081
Drug: Azapropazone 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azapropazone 1200 mg per day
Trial: 31837624
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral group therapy (CBGT)
Trial: 19346279
Drug: Naltrexone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (50 mg)
Trial: 28063907
Drug: Standard curriculum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard curriculum plus weekly video coaching by an expert laparoscopic surgeon
Trial: 19196468
Drug: Oral dihydrocodeine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dihydrocodeine
Trial: 16538135
Drug: Rewetting drops
RxNorm normalized name: Opti-Free Rewetting Drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rewetting drops (carboxymethylcellulose 0.5%, Refresh Contacts) twice per day
Trial: 12545629
Drug: 10 cc
RxNorm normalized name: CC
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 cc of 2% lidocaine gel in the endorectal (group 1)
Trial: 12545629
Drug: 10 cc
RxNorm normalized name: CC
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 cc of 1% lidocaine solution injected into the apex (group 2)
Trial: 9798805
Drug: L plus
RxNorm normalized name: Ionil Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L plus clarithromycin (C) 250 mg b.d. plus tinidazole (T) 500 mg b.d. for 7 days (LCT)
Trial: 9798805
Drug: RBC plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC plus C 250 mg b.d. and T 500 mg b.d. for 7 days (RbcCT)
Trial: 7617820
Drug: 50 mg/70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg/70 kg intravenous diphenhydramine
Trial: 23237788
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea (1600 mg EGCG and 600 mg caffeine)
Trial: 10495984
Drug: Olanzapine 10
RxNorm normalized name: olanzapine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine 10 mg/day
Trial: 27712774
Drug: No CTO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No CTO PCI (conservative treatment without PCI of the CTO)
Trial: 20458045
Drug: Intense dose-dense
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide (IDD-ETC) every 2 weeks
Trial: 20458045
Drug: Conventionally scheduled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventionally scheduled chemotherapy with epirubicin/cyclophosphamide followed by paclitaxel every three weeks
Trial: 12589345
Drug: Omalizumab (≥0.016
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omalizumab (≥0.016 mg/kg of IgE per 4 weeks)
Trial: 6440740
Drug: Levonorgestrel 20
RxNorm normalized name: ethinyl estradiol-levonorgestrel 20 mcg-90 mcg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levonorgestrel 20 mcg/day device
Trial: 19020749
Drug: Cetuximab (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetuximab (single agent)
Trial: 29274893
Drug: Standard behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard behavioral treatment (SBT)
Trial: 29274893
Drug: Acceptance-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acceptance-based treatment (ABT)
Trial: 30071866
Drug: Implementation success
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implementation success measures (e.g., # of peer groups held)
Trial: 17664952
Drug: Methotrexate plus
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate plus intramuscular gold
Trial: 17664952
Drug: Triple DMARD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple DMARD therapy
Trial: 11666125
Drug: TTFCA 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TTFCA 60 mg thrice daily (Group A)
Trial: 11666125
Drug: TTFCA 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TTFCA 30 mg thrice daily (Group B)
Trial: 8305420
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg conjugated equine estrogen (CEE) plus 10 mg medroxyprogesterone acetate (MPA)
Trial: 8305420
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg CEE only
Trial: 20418523
Drug: BoNT‐A (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BoNT‐A (500 U Dysport) injection
Trial: 15325934
Drug: Edaravone administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edaravone administration before myocardial reperfusion
Trial: 8058353
Drug: Baclofen administration
RxNorm normalized name: Baclofen
DrugBank: Baclofen (DB00181)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Baclofen administration (10 subjects)
Trial: 808194
Drug: Isotonic 5
RxNorm normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isotonic 5 percent crystalline amino acid solution
Trial: 2103529
Drug: Topical levobunolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical levobunolol treatment for four months
Trial: 22291112
Drug: Oral cefixime
RxNorm normalized name: Cefixime
DrugBank: Cefixime (DB00671)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral cefixime for 10 days
Trial: 22291112
Drug: Sequential intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential intravenous ceftriaxone for 4 days followed by oral cefixime for 6 days
Trial: 15821197
Drug: AM3 (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AM3 (3 g/d for 180 days)
Trial: 388401
Drug: tienilic acid
RxNorm normalized name: Tienilic acid
DrugBank: Tienilic acid (DB04831)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: tienilic acid (mean dose 210 mg)
Trial: 21118395
Drug: Omeprazole (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (10 mg once daily) plus mosapride citrate (5 mg three times a day)
Trial: 19391529
Drug: Auricular point
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auricular point taping and pressing therapy
Trial: 12383535
Drug: Misoprostol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol (200 microg) orally every hour for a maximum of three doses
Trial: 12383535
Drug: Placebo orally
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo orally every hour for a maximum of three doses
Trial: 9819040
Drug: Recombinant activated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant activated factor VII (rFVIIa) at 70 microg/kg dosage
Trial: 9819040
Drug: Recombinant activated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant activated factor VII (rFVIIa) at 35 microg/kg dosage
Trial: 7699549
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses of nebulized ipratropium bromide (250 micrograms/dose)
Trial: 7699549
Drug: One dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One dose of nebulized ipratropium bromide
Trial: 2539929
Drug: Eicosapentanoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentanoic acid (EPA) 10 g per day
Trial: 25369200
Drug: 600 µg
RxNorm normalized name: P.G. 600 KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 µg of misoprostol sublingually
Trial: 21953471
Drug: Ibandronate 100
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate 100 mg monthly
Trial: 25856225
Drug: Ibandronate 150
RxNorm normalized name: ibandronate 150 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate 150 mg monthly
Trial: 21953471
Drug: Ibandronate (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate (100 mg and 150 mg monthly)
Trial: 7867679
Drug: Acrivastine 16
RxNorm normalized name: Acrivastine
DrugBank: Acrivastine (DB09488)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acrivastine 16 mg
Trial: 1970907
Drug: Acrivastine 8
RxNorm normalized name: acrivastine 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acrivastine 8 mg
Trial: 10664928
Drug: Cetirizine 10
RxNorm normalized name: cetirizine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine 10 mg and 20 mg
Trial: 7888428
Drug: Ademetionin (therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ademetionin (therapy group)
Trial: 29875218
Drug: Dimethyl fumarate
RxNorm normalized name: Dimethyl Fumarate
DrugBank: Dimethyl fumarate (DB08908)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dimethyl fumarate (DMF) in treatment-naive patients
Trial: 7892014
Drug: Dextromethorphan (DM)
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dextromethorphan (DM) 30 mg
Trial: 7892014
Drug: Dextromethorphan (DM)
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dextromethorphan (DM) 45 mg
Trial: 7892014
Drug: Dextromethorphan (DM)
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dextromethorphan (DM) 15 mg
Trial: 12728166
Drug: Placebo spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo spray
Trial: 2831814
Drug: Once-daily use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily use of interferon
Trial: 22725836
Drug: Curcuminoid/piperine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcuminoid/piperine treatment (4 g curcuminoids plus 24 mg piperine)
Trial: 20957329
Drug: Psychological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychological treatment (problem-solving)
Trial: 16864148
Drug: E2/NETA (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2/NETA (2 mg E2 plus 1 mg NETA)
Trial: 7650224
Drug: 40-mg famotidine
RxNorm normalized name: famotidine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40-mg famotidine wafer
Trial: 7650224
Drug: 20-mg and
RxNorm normalized name: zinc pyrithione 20 MG/ML [Free and Clear]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20-mg and 40-mg famotidine wafers
Trial: 29371008
Drug: School-based program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: School-based program promoting outdoor activities (up to 11 hours weekly)
Trial: 22020318
Drug: Vorinostat 800
RxNorm normalized name: Vorinostat
DrugBank: Vorinostat (DB02546)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vorinostat 800 mg/day
Trial: 22020318
Drug: Vorinostat 1400
RxNorm normalized name: Vorinostat
DrugBank: Vorinostat (DB02546)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vorinostat 1400 mg/day
Trial: 16712781
Drug: schema focused
RxNorm normalized name: AVOBENZONE 0.2 g in 1 g / BUTYLENE GLYCOL 0.1 g in 1 g TOPICAL CREAM [Focused Corrective]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: schema focused therapy or transference focused psychotherapy
Trial: 19422627
Drug: Alcohol (0.82
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (0.82 g/kg)
Trial: 11956511
Drug: Indinavir (C(max)
DrugBank: Indinavir (DB00224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indinavir (C(max) > 7 microg/ml)
Trial: 11956511
Drug: Indinavir (C(max)
DrugBank: Indinavir (DB00224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indinavir (C(max) < 7 microg/ml)
Trial: 9822864
Drug: Greater than
RxNorm normalized name: immune globulin,alpha (IgA) greater than 50 mcg/mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Greater than normal expression of platelet-endothelial cell adhesion molecule-1 (PECAM-1) (57.1 +/- 2.3)
Trial: 31601466
Drug: Bone marrow
RxNorm normalized name: bone marrow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone marrow nucleated cell (BMNc) injection
Trial: 28619050
Drug: Brief Admission
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief Admission Skåne plus Treatment as Usual
Trial: 15674006
Drug: Massage therapy
RxNorm normalized name: CAMPHOR (SYNTHETIC) 30 g in 1 mL / MENTHOL 40 g in 1 mL TOPICAL OIL [CBDMEDIC MASSAGE THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage therapy (20 minutes, twice weekly, for 12 weeks)
Trial: 15674006
Drug: Friendly visit
RxNorm normalized name: Fisherman's Friend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Friendly visit (control group, reading, talking, playing quiet games, twice weekly for 12 weeks)
Trial: 8077977
Drug: Patient-controlled analgesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled analgesia (morphine)
Trial: 26098847
Drug: ARB (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARB (40 mg/day olmesartan) for eight weeks
Trial: 17717237
Drug: Transdermal scopolamine
RxNorm normalized name: Transderm Scop
DrugBank: Scopolamine (DB00747)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal scopolamine 1.5 mg
Trial: 16243989
Drug: IV ondansetron
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV ondansetron 4 mg
Trial: 29415730
Drug: Pre‐ and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre‐ and postnatal small‐quantity lipid‐based nutrient supplements for both mother and child
Trial: 27464984
Drug: IPE-27 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IPE-27 (10 g/day)
Trial: 12670816
Drug: Epidural 10
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural 10 mL saline injection
Trial: 8595991
Drug: Drug combinations
RxNorm normalized name: Other anti-dementia drug combinations in ATC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug combinations for Helicobacter pylori eradication
Trial: 1572460
Drug: Thrombolysis (TL)
RxNorm normalized name: thrombocytin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolysis (TL) using 30 mg rt-PA
Trial: 12791814
Drug: Valsartan (40-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (40-80 mg/d)
Trial: 6203784
Drug: Serial hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Serial hormone determinations (beta‐hCG, HPL, P, 17‐OHP, E2 and E3)
Trial: 6203784
Drug: Combined determination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined determination of all hormones
Trial: 30047816
Drug: Pharmaceutical Care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmaceutical Care (PC) group
Trial: 7598243
Drug: metoclopramide 10
RxNorm normalized name: metoclopramide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoclopramide 10 mg
Trial: 12402733
Drug: Esmolol 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol 80 mg
Trial: 7709938
Drug: Current treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current treatments for osteoporosis
Trial: 7709938
Drug: Preventive treatments
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive treatments
Trial: 2062395
Drug: Pulmonary rehabilitation
RxNorm normalized name: Lobaria pulmonaria extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulmonary rehabilitation (optimal medical treatment, training of physical endurance, health education, psychological and social support) for 3 months, 38 hours a week
Trial: 24158248
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (EPA) 1,800 mg daily plus statin (EPA group, n = 40)
Trial: 8570263
Drug: Amiloride (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiloride (10 mg oral dose)
Trial: 2212182
Drug: Comprehensive community
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive community programming for drug abuse prevention (school, parent, mass media, and community organization)
Trial: 30520977
Drug: Twice-daily chemoradiotherapy
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily chemoradiotherapy (45 Gy in 30 fractions)
Trial: 28251321
Drug: Tramadol 2
RxNorm normalized name: traMADol 25 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 2 mg/kg diluted in normal saline up to 2 cc total volume injected before surgery
Trial: 23241931
Drug: Meriva (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meriva (2 tablets/day, 2 x 500 mg of Meriva/day, corresponding to 2 x 100 mg curcumin/day)
Trial: 11699613
Drug: Rabeprazole 10
RxNorm normalized name: RABEprazole 10 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 10 mg once daily for 8 days
Trial: 9591497
Drug: Oral HRT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral HRT (2 mg of estradiol on days 1‐12, 2 mg of estradiol plus 1 mg of norethisterone acetate on days 13‐22, and 1 mg of estradiol on days 23‐28; n = 21)
Trial: 9591497
Drug: Transdermal HRT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal HRT (50 microg/d of estradiol on days 1‐28 followed by 250 microg/d of norethisterone acetate on days 14‐28; n = 21)
Trial: 9591497
Drug: Transdermal HRT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal HRT (50 microg/d of estradiol on days 1‐28 followed by 250 microg/d of norethisterone acetate on days 14‐28; n = 10 female smokers)
Trial: 11531899
Drug: Sumatriptan 6
RxNorm normalized name: sumatriptan 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan 6 mg
Trial: 3348073
Drug: Morphine-scopolamine 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine-scopolamine 0.15 mg kg‐1 and 0.0065 mg kg‐1
Trial: 29277968
Drug: Insulin monotherapy
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin monotherapy (placebo)
Trial: 27374748
Drug: Alisporivir (Debio
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alisporivir (Debio 025) in combination with pegylated interferon‐α2a
Trial: 26359998
Drug: High-potency topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-potency topical corticosteroid (betamethasone dipropionate)
Trial: 2435071
Drug: Metoprolol (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (daily dose up to 200 mg) without invasive testing (group II)
Trial: 6127501
Drug: Vitamin-D therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin-D therapy
Trial: 30591031
Drug: Valerian capsules
DrugBank: Valerian (DB13196)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valerian capsules
Trial: 11836281
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg TU im at wk 2, 6, 12, and 18 combined with 400 mg NETE im at wk 0, 6, 12, and 18 (group II)
Trial: 11836281
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg TU im at wk 2, 6, 12, and 18 with daily oral NET acetate (NETA) from wk 0 to 24 (group III)
Trial: 29270003
Drug: Fixed-dose combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose combination (FDC) of telmisartan 40 mg and S-amlodipine 5 mg
Trial: 29270003
Drug: Both interventions
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both interventions (FDC and concomitant administration)
Trial: 23819227
Drug: Abdominal cluster‐needling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abdominal cluster‐needling therapy
Trial: 19341989
Drug: Yoga classes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoga classes (twice weekly for 90 minutes over two months)
Trial: 16881929
Drug: Multi-micronutrient Sprinkles
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-micronutrient Sprinkles with 30 mg iron as ferrous fumarate
Trial: 16881929
Drug: Multi-micronutrient Sprinkles
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-micronutrient Sprinkles with 20 mg iron as ferric pyrophosphate
Trial: 16881929
Drug: Iron drops
RxNorm normalized name: Iron Drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron drops with 12.5 mg iron as liquid ferrous sulphate
Trial: 15450574
Drug: Cisplatin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (80 mg/m(2)) and docetaxel (60 mg/m(2)) chemotherapy prior to surgery (neoadjuvant group)
Trial: 15450574
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (surgery without any previous chemotherapy)
Trial: 11264760
Drug: Budesonide 100
RxNorm normalized name: budesonide 100 MCG/ACTUAT Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 100 microg twice daily via Turbuhaler
Trial: 11264760
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) 400 microg daily via pMDI
Trial: 11264760
Drug: Budesonide 800
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide 800 microg daily via Turbuhaler
Trial: 2679681
Drug: mezlocillin/oxacillin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mezlocillin/oxacillin (2 g:1 g)
Trial: 1099501
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy consisting of DTIC with adriamycin, CCNU, or hydroxyurea.
Trial: 1099501
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy with adriamycin and DTIC.